NCT00795262 - Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

DiabetesHypertension

Interventions

DRUG

Quinapril (Accupril) plus Alpha Lipoic Acid

Patients in Arm 2 (n=20) will receive quinapril 40 mg and Alpha Lipoic Acid (600 mg/day)for an 8-week treatment period (Treatment A).

DRUG

accupril, placebo

accupril 40 mg

DRUG

accupril, alpha lipoic acid

accupril (quinapril) 40 mg plus alpha lipoic acid 600 mg

Trial Locations (1)

Atlanta Vascular Research Foundation, Tucker